• 
  Léa Flippe, Anne Gaignerie, Céline Sérazin, Olivier Baron, Xavier Saulquin, et al.. Rapid and Reproducible Differentiation of Hematopoietic and T Cell Progenitors From Pluripotent Stem Cells. Frontiers in Cell and Developmental Biology, 2020, 8, ⟨10.3389/fcell.2020.577464⟩. ⟨hal-03031624⟩
• 
  Vanessa Gauttier, Sabrina Pengam, Justine Durand, Kevin Biteau, Caroline Mary, et al.. Selective SIRPα blockade reverses tumor T cell exclusion and overcomes cancer immunotherapy resistance. Journal of Clinical Investigation, 2020, 130 (11), pp.6109-6123. ⟨10.1172/JCI135528⟩. ⟨hal-03001660⟩
• 
  Laure-Marie Dardaud, Céline Bris, Valérie Desquiret-Dumas, Blandine Boisselier, Emeline Tabouret, et al.. High mitochondrial DNA copy number is associated with longer survival in young patients with glioblastoma. Neuro-Oncology, 2019, 21 (8), pp.1084-1085. ⟨10.1093/neuonc/noz072⟩. ⟨hal-02616951⟩
• 
  Wendy Revailler, Anne Ségolène Cottereau, Cédric Rossi, Rudy Noyelle, Thomas Trouillard, et al.. Deep Learning Approach to Automatize TMTV Calculations Regardless of Segmentation Methodology for Major FDG-Avid Lymphomas.. Diagnostics, 2022, Diagnostics, 12 (2), pp.417. ⟨10.3390/diagnostics12020417⟩. ⟨hal-04609336⟩
• 
  A. Stathis, M. C. Pirosa, L. Orsucci, Pierre Feugier, M. Tani, et al.. IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma.. Haematologica, 2024, Haematologica, Online ahead of print. ⟨10.3324/haematol.2023.283918⟩. ⟨hal-04604597⟩
• 
  Nora Bouhsina, Cyrille Decante, Jean-Baptiste Hardel, Dominique Rouleau, Jérôme Abadie, et al.. Comparison of MRI T1, T2, and T2* mapping with histology for assessment of intervertebral disc degeneration in an ovine model. Scientific Reports, 2022, 12 (1), pp.12. ⟨10.1038/s41598-022-09348-w⟩. ⟨hal-04602235⟩
• 
  Faraj Fajloun. Maladies tropicales négligées à manifestations cutanées : vers un développement de nouvelles stratégies préventives, de diagnostic et de traitement.. Médecine humaine et pathologie. Université d'Angers; École doctorale des Sciences et de Technologie (Beyrouth), 2023. Français. ⟨NNT : 2023ANGE0040⟩. ⟨tel-04597852⟩
• 
  Clément Bailly, Sébastien Gouard, François Guérard, Benjamin Chalopin, Thomas Carlier, et al.. What is the Best Radionuclide for Immuno-PET of Multiple Myeloma? A Comparison Study Between 89Zr- and 64Cu-Labeled Anti-CD138 in a Preclinical Syngeneic Model. International Journal of Molecular Sciences, 2019, 20 (10), pp.2564. ⟨10.3390/ijms20102564⟩. ⟨hal-02141555⟩
• 
  Jennifer Derrien, Catherine Guérin-Charbonnel, Victor Gaborit, Loïc Campion, Magali Devic, et al.. The DNA methylation landscape of multiple myeloma shows extensive inter- and intrapatient heterogeneity that fuels transcriptomic variability. Genome Medicine, 2021, 13 (1), pp.127. ⟨10.1186/s13073-021-00938-3⟩. ⟨hal-03333684⟩
• 
  Marie Denis Musquer, Nicolas Jouand, Morgane Pere, Juliette Eugène Lamer, Stéphane Bézieau, et al.. High-Density of FcγRIIIA+ (CD16+) Tumor-Associated Neutrophils in Metastases Improves the Therapeutic Response of Cetuximab in Metastatic Colorectal Cancer Patients, Independently of the HLA-E/CD94-NKG2A Axis. Frontiers in Oncology, 2021, 11, ⟨10.3389/fonc.2021.684478⟩. ⟨hal-03292120⟩

1 049

339